Clinical Trials
16
Active:4
Completed:4
Trial Phases
3 Phases
Phase 2:4
Phase 3:6
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 3
6 (46.2%)Phase 2
4 (30.8%)Not Applicable
3 (23.1%)Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients
Phase 3
Not yet recruiting
- Conditions
- Multiple Myeloma, Newly Diagnosed
- Interventions
- Drug: Daratumumab SC (Darzalex)Procedure: Autologous Stem Cell Transplantation
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 824
- Registration Number
- NCT06918002
Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
Active, not recruiting
- Conditions
- Multiple Myeloma
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 200
- Registration Number
- NCT06062537
- Locations
- 🇫🇷
CHU Amiens Picardie, Amiens, France
🇫🇷CH d'ANNECY, Annecy, France
🇫🇷Centre hospitalier d'Argenteuil, Argenteuil, France
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
Recruiting
- Conditions
- Multiple Myeloma
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 180
- Registration Number
- NCT05208086
- Locations
- 🇫🇷
Ch Annecy Genevois, Annecy, France
🇫🇷Centre Hospitalier William Morey, Chalon Sur Saone, France
🇫🇷Centre Hospitalier Métropole de Savoie, Chambéry, France
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 46
- Registration Number
- NCT05066607
- Locations
- 🇫🇷
CHU Amiens-Picardie, Amiens, France
🇫🇷CHRU - Hôpital du Bocage, Angers, France
🇫🇷CHU Caen - Côte de Nacre, Caen, France
MInimal Residual Disease Adapted Strategy
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 791
- Registration Number
- NCT04934475
- Locations
- 🇧🇪
Institut Jules Bordet, Bruxelles, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇧🇪Grand Hôpital de Charleroi - Site de Notre-Dame, Charleroi, Belgium
- Prev
- 1
- 2
- 3
- Next
News
No news found